Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 4
1992 3
1994 1
1995 2
1997 2
1998 3
1999 3
2000 1
2001 1
2002 2
2003 1
2004 1
2005 6
2006 5
2007 7
2008 5
2009 8
2010 7
2011 10
2012 9
2013 15
2014 12
2015 9
2016 8
2017 7
2018 18
2019 20
2020 19
2021 11
2022 13
2023 9
2024 8
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Do patients benefit from omega-3 fatty acids?
Sherratt SCR, Mason RP, Libby P, Steg PG, Bhatt DL. Sherratt SCR, et al. Cardiovasc Res. 2024 Feb 17;119(18):2884-2901. doi: 10.1093/cvr/cvad188. Cardiovasc Res. 2024. PMID: 38252923 Free PMC article. Review.
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.
Burger PM, Bhatt DL, Dorresteijn JAN, Koudstaal S, Mosterd A, Martens FMAC, Steg PG, Visseren FLJ; REDUCE-IT Investigators. Burger PM, et al. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):488-499. doi: 10.1093/ehjcvp/pvae030. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38678009 Free PMC article. Clinical Trial.
Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA).
Miyauchi K, Iwata H, Nishizaki Y, Inoue T, Hirayama A, Kimura K, Ozaki Y, Murohara T, Ueshima K, Kuwabara Y, Tanaka-Mizuno S, Yanagisawa N, Sato T, Daida H; RESPECT-EPA Investigators. Miyauchi K, et al. Circulation. 2024 Aug 6;150(6):425-434. doi: 10.1161/CIRCULATIONAHA.123.065520. Epub 2024 Jun 14. Circulation. 2024. PMID: 38873793 Clinical Trial.
A Critical Review of Icosapent Ethyl in Cardiovascular Risk Reduction.
Huston J, Schaffner H, Cox A, Sperry A, Mcgee S, Lor P, Langley L, Skrable B, Ashchi M, Bisharat M, Gore A, Jones T, Sutton D, Sheikh-Ali M, Berner J, Goldfaden R. Huston J, et al. Am J Cardiovasc Drugs. 2023 Jul;23(4):393-406. doi: 10.1007/s40256-023-00583-8. Epub 2023 May 15. Am J Cardiovasc Drugs. 2023. PMID: 37188993 Free PMC article. Review.
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial.
Mischoulon D, Dunlop BW, Kinkead B, Schettler PJ, Lamon-Fava S, Rakofsky JJ, Nierenberg AA, Clain AJ, Mletzko Crowe T, Wong A, Felger JC, Sangermano L, Ziegler TR, Cusin C, Fisher LB, Fava M, Rapaport MH. Mischoulon D, et al. J Clin Psychiatry. 2022 Aug 22;83(5):21m14074. doi: 10.4088/JCP.21m14074. J Clin Psychiatry. 2022. PMID: 36005883 Clinical Trial.
205 results